Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Reports add new data to breast cancer research
November 18th, 2005
Data on breast cancer are outlined in reports from Canada and Italy. Study 1: The effect of chemotherapy-induced amenorrhea during adjuvant therapy was studied recently by scientists in Canada. Scientists sought "To investigate the therapeutic impact of chemotherapy-induced amenorrhea in premenopausal patients with breast cancer" by conducting "a retrospective cohort study of a National Cancer Institute of Canada Clinical Trials Group phase III trial involving premenopausal patients randomized to receive cyclophosphamide, methotrexate, and fluorouracil (CMF), versus intensive cyclophosphamide, epirubicin, and fluorouracil (CEF)." ...
Source: Drug Week (2005-11-18)
|
